Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawahar Kopparam

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|April 29, 2020
A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibitionSantiago Gisler, Ana Rita R Maia, Gayathri Chandrasekaran, et al.
Cell Death and Differentiation|June 3, 2017
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiationJawahar Kopparam, Johanna Chiffelle, Paolo Angelino, et al.
British Journal of Cancer|March 23, 2024
Combination of EZH2 and ATM inhibition in BAP1-deficient mesotheliomaNick Landman, Danielle Hulsman, Jitendra Badhai, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancerSasmit Sarangi, Ambarish Pandey, Anne-Laure Papa, et al.
Cancer Research|October 15, 2013
Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacyAmbarish Pandey, Ashish Kulkarni, Bhaskar Roy, et al.
Communications Biology|February 21, 2026
PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibitionJawahar Kopparam, Gayathri Chandrasekaran, Danielle Hulsman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicityPoulomi Sengupta, Sudipta Basu, Shivani Soni, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|April 29, 2020
A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibitionSantiago Gisler, Ana Rita R Maia, Gayathri Chandrasekaran, et al.
Cell Death and Differentiation|June 3, 2017
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiationJawahar Kopparam, Johanna Chiffelle, Paolo Angelino, et al.
British Journal of Cancer|March 23, 2024
Combination of EZH2 and ATM inhibition in BAP1-deficient mesotheliomaNick Landman, Danielle Hulsman, Jitendra Badhai, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancerSasmit Sarangi, Ambarish Pandey, Anne-Laure Papa, et al.
Cancer Research|October 15, 2013
Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacyAmbarish Pandey, Ashish Kulkarni, Bhaskar Roy, et al.
Communications Biology|February 21, 2026
PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibitionJawahar Kopparam, Gayathri Chandrasekaran, Danielle Hulsman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicityPoulomi Sengupta, Sudipta Basu, Shivani Soni, et al.
Pageof 1